GALR3

GALR3 is a Gi/Go-coupled G protein-coupled receptor for galanin that functions in neuromodulation, neural stem/progenitor cell survival, and hippocampal progenitor proliferation. It binds galanin with high affinity (KD ~1–2 nM) and signals primarily through inhibition of adenylate cyclase and activation of GIRK potassium channels, producing inward K+ currents consistent with inhibitory neuromodulation (PMID:9722565, PMID:9832121). GALR3 mRNA and protein are expressed in restricted hypothalamic, limbic, and brainstem nuclei—including the locus coeruleus where it colocalizes with tyrosine hydroxylase—implicating it in regulation of noradrenergic, feeding, and nociceptive circuits (PMID:12406501, PMID:15514977). GALR3 activation promotes neural stem cell survival under glucolipotoxic stress by suppressing apoptosis and the unfolded protein response, and specifically mediates galanin-driven proliferation of postnatal hippocampal progenitors (PMID:23927369, PMID:28431685).

1. 1998 High

   The identity and signaling mechanism of a third galanin receptor subtype were established: GALR3 was cloned, shown to bind galanin with high affinity, and demonstrated to activate GIRK potassium channels and inhibit adenylate cyclase via Gi/Go coupling, distinguishing its signaling from the PLC-coupled GALR2.

   Evidence Expression cloning from rat hypothalamus, radioligand binding, Xenopus oocyte electrophysiology with GIRK1/GIRK4, aequorin luminescence in HEK-293 cells, and melanophore assay

   PMID:9722565 PMID:9832121

   Open questions at the time

   • No structural model of GALR3 or basis for Gi selectivity over other G proteins
   • Endogenous neuronal signaling not yet confirmed
2. 2002 Medium

   The CNS expression map of GALR3 was defined, revealing a highly restricted distribution in hypothalamic, limbic, and brainstem nuclei consistent with roles in feeding, autonomic, and nociceptive circuits—constraining where GALR3 could act in vivo.

   Evidence In situ hybridization and RNase protection in rat brain

   PMID:12406501

   Open questions at the time

   • Single detection method (mRNA only); protein-level confirmation needed
   • Functional consequence of expression in each nucleus not tested
3. 2004 Medium

   Protein-level expression of GALR3 in catecholaminergic neurons was established by colocalization with tyrosine hydroxylase in the locus coeruleus, VTA, and substantia nigra, linking GALR3 to regulation of noradrenergic and dopaminergic transmission.

   Evidence Double-label immunohistochemistry in rat brain

   PMID:15514977

   Open questions at the time

   • Antibody specificity not validated in GALR3-knockout tissue
   • No electrophysiological or biochemical evidence that GALR3 modulates catecholamine release
4. 2005 Medium

   Pharmacological reassessment revealed that galanin(2-11) and the antagonists M35/M40 are not GalR2-selective but also engage GalR3, requiring reinterpretation of earlier in vivo studies, while GalR3 expression in the locus coeruleus was shown to be independent of cAMP-dependent regulation and galanin availability.

   Evidence Radioligand binding competition in transfected cells; Western blot and RT-PCR in Cath.a cells and galanin knockout mice

   PMID:15934937 PMID:15944007

   Open questions at the time

   • Mechanism controlling GALR3 basal expression remains unknown
   • Lack of truly selective GALR3 agonists limits in vivo functional dissection
5. 2013 Medium

   A functional role for GALR3 beyond classical neuromodulation was revealed: GALR3 activation protects adult neural stem cells from glucolipotoxicity-induced apoptosis by reducing cleaved caspase-3, increasing Bcl-2, and suppressing the unfolded protein response marker CHOP, while its poor cell-surface trafficking in recombinant systems was formally characterized.

   Evidence Apoptosis and UPR marker assays in primary SVZ-derived NSCs; receptor engineering and cAMP biosensor assay for surface expression

   PMID:23927369 PMID:24116939

   Open questions at the time

   • Anti-apoptotic signaling pathway downstream of Gi coupling not fully delineated
   • Poor surface trafficking mechanism unresolved—no structural or chaperone basis identified
   • Neuroprotective role tested in single lab and single stress paradigm
6. 2017 Medium

   GALR3, not GALR2, was identified as the receptor mediating galanin-driven proliferation of postnatal hippocampal progenitor cells, resolved through pharmacological epistasis with subtype-selective tools.

   Evidence Selective GalR3 antagonist SNAP 37889 abolished Gal(2-11)-induced proliferation; GalR2 agonist M1145 had no effect in rat hippocampal progenitor cultures

   PMID:28431685

   Open questions at the time

   • Genetic confirmation (GALR3 knockdown/knockout in progenitors) not performed
   • Downstream proliferative signaling pathway from GALR3 not characterized
7. 2020 Low

   Transcriptional regulation of GALR3 was placed downstream of TLR4-mediated fatty acid sensing, with PKC, JNK, ERK, and p38 kinases controlling palmitate-induced Galr3 upregulation in hypothalamic GnRH neurons.

   Evidence Pharmacological inhibitor panel and RT-PCR in mHypoA-GnRH/GFP cell line

   PMID:32841709

   Open questions at the time

   • Single immortalized cell line with pharmacological inhibitors only; no genetic validation of TLR4 requirement
   • Functional consequence of GALR3 upregulation in GnRH neurons not tested
   • Relevance to in vivo metabolic or reproductive regulation unconfirmed

• Key unresolved questions include the structural basis of GALR3's poor surface trafficking, the downstream signaling intermediates connecting Gi coupling to anti-apoptotic and proliferative outcomes in neural progenitors, and in vivo validation of GALR3-specific functions using genetic loss-of-function models.
• No GALR3-selective agonist validated in vivo
• No GALR3-knockout phenotypic characterization published in the timeline
• Structural basis for receptor subtype selectivity and trafficking unknown